Condensed Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	ATM Offering Program	Public offering	February / March 2024 Public Offering Sale	Common Stock	Common Stock ATM Offering Program	Common Stock Public offering	Common Stock February / March 2024 Public Offering Sale	Additional Paid-in Capital	Additional Paid-in Capital ATM Offering Program	Additional Paid-in Capital Public offering	Additional Paid-in Capital February / March 2024 Public Offering Sale	Accumulated Other Comprehensive Loss	Accumulated Deficit
Stockholders' Equity, beginning balances at Dec. 31, 2022	$ 231,337				$ 3				$ 547,020				$ (1,196)	$ (314,490)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2022					32,626,627
Issuance of common stock upon exercise of stock options	1,135								1,135
Issuance of common stock upon exercise of stock options (in shares)					122,207
Issuance of common stock, net of issuance costs		$ 9,647								$ 9,647
Issuance of common stock, net of issuance costs (in shares)						487,934
Stock-based compensation expense	4,221								4,221
Vesting of common stock warrants issued for services	22								22
Net unrealized gain (loss) on marketable securities	926												926
Net loss	(28,682)													(28,682)
Stockholders' Equity, ending balances at Mar. 31, 2023	218,606				$ 3				562,045				(270)	(343,172)
Stockholders' Equity, ending balances (in shares) at Mar. 31, 2023					33,236,768
Stockholders' Equity, beginning balances at Dec. 31, 2022	231,337				$ 3				547,020				(1,196)	(314,490)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2022					32,626,627
Net unrealized gain (loss) on marketable securities	1,541
Net loss	(58,298)
Stockholders' Equity, ending balances at Jun. 30, 2023	325,144				$ 4				697,583				345	(372,788)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2023					42,016,622
Stockholders' Equity, beginning balances at Mar. 31, 2023	218,606				$ 3				562,045				(270)	(343,172)
Stockholders' Equity, beginning balances (in shares) at Mar. 31, 2023					33,236,768
Issuance of common stock upon exercise of stock options	894								894
Issuance of common stock upon exercise of stock options (in shares)					72,217
Issuance of common stock, net of issuance costs			$ 129,208				$ 1				$ 129,207
Issuance of common stock, net of issuance costs (in shares)							8,625,000
Issuance of common stock - 2020 ESPP	658								658
Issuance of common stock - 2020 ESPP (in shares)					82,637
ATM offering costs		(212)								(212)
Stock-based compensation expense	4,969								4,969
Vesting of common stock warrants issued for services	22								22
Net unrealized gain (loss) on marketable securities	615												615
Net loss	(29,616)													(29,616)
Stockholders' Equity, ending balances at Jun. 30, 2023	325,144				$ 4				697,583				345	(372,788)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2023					42,016,622
Stockholders' Equity, beginning balances at Dec. 31, 2023	307,829				$ 4				723,136				16	(415,327)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2023					43,075,218
Issuance of common stock upon exercise of stock options and vesting of RSUs	3,113								3,113
Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares)					236,856
Issuance of common stock, net of issuance costs				$ 316,149				$ 1				$ 316,148
Issuance of common stock, net of issuance costs (in shares)								7,845,314
Stock-based compensation expense	5,974								5,974
Vesting of common stock warrants issued for services	22								22
Net unrealized gain (loss) on marketable securities	(125)												(125)
Net loss	(32,401)													(32,401)
Stockholders' Equity, ending balances at Mar. 31, 2024	600,561				$ 5				1,048,393				(109)	(447,728)
Stockholders' Equity, ending balances (in shares) at Mar. 31, 2024					51,157,388
Stockholders' Equity, beginning balances at Dec. 31, 2023	$ 307,829				$ 4				723,136				16	(415,327)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2023					43,075,218
Issuance of common stock upon exercise of stock options (in shares)	296,183
Net unrealized gain (loss) on marketable securities	$ (309)
Net loss	(67,354)
Stockholders' Equity, ending balances at Jun. 30, 2024	588,340				$ 5				1,071,309				(293)	(482,681)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2024					51,914,275
Stockholders' Equity, beginning balances at Mar. 31, 2024	600,561				$ 5				1,048,393				(109)	(447,728)
Stockholders' Equity, beginning balances (in shares) at Mar. 31, 2024					51,157,388
Issuance of common stock upon exercise of stock options and vesting of RSUs	850								850
Issuance of common stock upon exercise of stock options and vesting of RSUs (in shares)					81,290
Issuance of common stock, net of issuance costs		$ 15,263								$ 15,263
Issuance of common stock, net of issuance costs (in shares)						585,938
Issuance of common stock - 2020 ESPP	707								707
Issuance of common stock - 2020 ESPP (in shares)					89,659
Stock-based compensation expense	6,074								6,074
Vesting of common stock warrants issued for services	22								22
Net unrealized gain (loss) on marketable securities	(184)												(184)
Net loss	(34,953)													(34,953)
Stockholders' Equity, ending balances at Jun. 30, 2024	$ 588,340				$ 5				$ 1,071,309				$ (293)	$ (482,681)
Stockholders' Equity, ending balances (in shares) at Jun. 30, 2024					51,914,275